For Covered Entities, Integrated Care is No Longer an Option

SPONSORED CONTENT

While health leaders have touted the “whole health” approach of integrated healthcare for decades as a way to provide patients with better, more cost-effective care, the COVID-19 pandemic significantly

Read More »

Making the Most of Your 340B Program with a Comprehensive Pharmacy Strategy

SPONSORED CONTENT

The world of 340B has been in a state of dynamic change for several years. The covered entities navigating it with the most success have comprehensive pharmacy strategies. This helps them maximize both the value of their participation and the opportunities provided by

Read More »

Visante Webinar: 340B Current Issues and Policy Update

SPONSORED CONTENT

Join us for in an informative and timely 340B webinar scheduled for March 13th at 11:30 AM CT! Ted Slafsky, CEO of 340B Report, and Kristin Fox-Smith from Visante will share insights on 340B policy and litigation updates, along with valuable strategies to

Read More »

Part 2 of 2: Understanding the Top Five Challenges Facing Health Center Pharmacies Today

Holly Russo headshot

SPONSORED CONTENT

Part 2 of 2: Navigating staffing shortages, unpredictable demand, and complex industry requirements

While in-house pharmacies offer a wide array of benefits both for the community health center (CHC) and their patient

Read More »

Part 1 of 2: Understanding the Top Five Challenges Facing Health Center Pharmacies Today

Holly Russo headshot

SPONSORED CONTENT

Part 1 of 2: Managing costs and ensuring favorable contracting

As industry veterans know too well, having an in-house pharmacy can be greatly beneficial for both community health centers (CHCs) and

Read More »

Reflecting on Winter Coalition 2024

SPONSORED CONTENT

Last week, the 340B community gathered in the sun-soaked city of San Diego to gain insights, exchange best practices, and navigate the evolving complexities surrounding the program. Whether you missed the 340B Coalition winter event altogether or are seeking a recap to share

Read More »

Essential Practices for HRSA Audit Preparedness

SPONSORED CONTENT

The Health Resources and Services Administration (HRSA) conducts randomized audits to assess compliance with the 340B drug pricing program, a federal initiative aimed at providing discounted medications to eligible entities. With more than 13,100 parent entities participating in 340B, this increased

Read More »

Prepping for HRSA Audits

SPONSORED CONTENT

Are you truly ready for a HRSA audit? Today we have two 340B experts, Dennis Killian and Heather Erickson, from CPS Solutions, LLC. (CPS) here to discuss three topics that will help you prepare. CPS has managed 340B Programs for hospitals and health systems since the

Read More »

Unlocking the Value of 340B Consultants: Their Roles and Responsibilities

SPONSORED CONTENT

In the complex landscape of healthcare, the 340B program plays a vital role in ensuring that vulnerable patients with limited financial resources have access to affordable medications. It enables qualified covered entities to maximize their resources and offer a wider range of benefits and services

Read More »

340B Webinar—State of 340B in 2024: Biggest Developments Expected this Year

SPONSORED CONTENT

Join our webinar for a comprehensive exploration of the current status of the 340B program, featuring a review of major industry trends from 2023 and key developments anticipated for 2024.
We’ll discuss what entities should expect and prepare for in the upcoming year,

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live